...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING

【24h】

COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING

机译：北欧地区英夫利昔单抗，依那西普和阿达木单抗治疗的类风湿关节炎患者的卫生保健费用比较

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Gokhale S. B.; Cassel T.; Mahon R.; Balkin P. E.; Singh S.; Bhattacharyya S.; Handin J.; Mendoza C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING [J] . Gokhale S. B., Cassel T., Mahon R., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：北欧地区英夫利昔单抗，依那西普和阿达木单抗治疗的类风湿关节炎患者的卫生保健费用比较
2. INCIDENCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA TREATED WITH ADALIMUMAB, ETANERCEPT, OR INFLIXIMAB IN A REAL-WORLD SETTING [J] . Maid Pablo, Real Rosa, Pedersen Ron, Journal of clinical rheumatology . 2016,第3期

机译：在真实世界中使用阿达木单抗，依那西普或英夫昔单抗治疗的阿根廷类风湿关节炎患者中的抗药性抗体的发生率
3. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: Results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry [J] . VanDartelS.A.A., FransenJ., KievitW., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2013,第6期

机译：阿达木单抗，英夫利昔单抗和依那西普治疗的类风湿关节炎患者发生严重感染风险的差异：荷兰类风湿关节炎监测（DREAM）注册的结果
4. Human Antichimeric Antibodies to Infliximab and Infusion-Related Allergic Reactions in Patients with Rheumatoid Arthritis [C] . D. Wouters, S. Stapel, M. Vis, Collegium Internationale Allergologicum . 2007

机译：人的苯甲酸纤维化率和类风湿性关节炎患者的infumency相关过敏反应的抗体抗体
5. The Efficacy of Therapeutic Drug Monitoring of Rheumatoid Arthritis Patients on Infliximab [D] . Abolhosn, Rania. 2018

机译：类风湿性关节炎患者治疗药物监测对英夫利昔单抗的疗效
6. The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab etanercept or infliximab: Results from a multinational real-world clinical practice non-interventional study [O] . Robert J. Moots, Ricardo M. Xavier, Chi Chiu Mok, -1

机译：抗药物抗体对使用阿达木单抗依那西普或英夫利昔单抗治疗的类风湿关节炎患者的药物浓度和临床结局的影响：一项来自跨国现实世界的临床实践的非干预性研究结果
7. Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated With Infliximab, Etanercept And Adalimumab In Nordic Setting [O] . SB Gokhale, T Cassel, R Mahon, 2016

机译：北欧环境中英夫利昔单抗，涅安普和亚达尔单抗治疗类风湿性关节炎患者的医疗成本比较

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号